SH
Insider selling
Stephen Hoge sold $3.6M of MRNA stock
Stephen Hoge, President of Moderna, Inc. (MRNA), sold 53,336 shares of MRNA stock worth $3.6M, per an SEC Form 4 filed Jul 16, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 15, 2026, 1 day before it was made public.
MRNA has moved +254.5% since the trade date, from $68.28 to $242.08 (Oct 20, 2026 close).
- Traded
- Jul 15, 2026
- Disclosed
- Jul 16, 2026
- Filing delay
- 1 day
- Price since
- +254.5%
- Role
- President
- Source
- SEC Form 4
More MRNA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.